Superior vena cava syndrome surgery: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Superior vena cava syndrome}} | {{Superior vena cava syndrome}} | ||
{{CMG}} | {{CMG}}{{AE}}{{MV}} | ||
==Overview== | ==Overview== | ||
Elective stent placement and surgical bypass is recommended for all patients who develop superior vena cava syndrome. | |||
==Surgery== | ==Surgery== | ||
Line 10: | Line 10: | ||
There have been numerous small studies using an intravascular expandable stent to reopen the occluded [[SVC]]; however, no prospectively designed comparative studies have been published. The reported response rates have been about 90% or greater. There is no agreement on the need for [[anticoagulant]] therapy after stent placement. In one series that used anticoagulant therapy for patients as part of the treatment protocol, there were reports of re-occlusion after this therapy was stopped. However, in another study, 17 [[cancer]] patients who were treated with stents and who did not have anticoagulant therapy had no occlusions. | There have been numerous small studies using an intravascular expandable stent to reopen the occluded [[SVC]]; however, no prospectively designed comparative studies have been published. The reported response rates have been about 90% or greater. There is no agreement on the need for [[anticoagulant]] therapy after stent placement. In one series that used anticoagulant therapy for patients as part of the treatment protocol, there were reports of re-occlusion after this therapy was stopped. However, in another study, 17 [[cancer]] patients who were treated with stents and who did not have anticoagulant therapy had no occlusions. | ||
===Surgical Bypass=== | ===Surgical Bypass=== | ||
Surgical bypass | Surgical bypass is more appropriate for patients with a [[benign]] obstruction than with a [[malignant]] obstruction, although surgical bypass has also been used for patients with malignant obstructions. | ||
==References== | ==References== | ||
Line 16: | Line 16: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] |
Revision as of 20:19, 13 January 2016
Superior Vena Cava Syndrome Microchapters |
Differentiating Superior Vena Cava Syndrome from Other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Superior vena cava syndrome surgery On the Web |
American Roentgen Ray Society Images of Superior vena cava syndrome surgery |
Directions to Hospitals Treating Superior vena cava syndrome |
Risk calculators and risk factors for Superior vena cava syndrome surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Elective stent placement and surgical bypass is recommended for all patients who develop superior vena cava syndrome.
Surgery
Stent Placement
There have been numerous small studies using an intravascular expandable stent to reopen the occluded SVC; however, no prospectively designed comparative studies have been published. The reported response rates have been about 90% or greater. There is no agreement on the need for anticoagulant therapy after stent placement. In one series that used anticoagulant therapy for patients as part of the treatment protocol, there were reports of re-occlusion after this therapy was stopped. However, in another study, 17 cancer patients who were treated with stents and who did not have anticoagulant therapy had no occlusions.
Surgical Bypass
Surgical bypass is more appropriate for patients with a benign obstruction than with a malignant obstruction, although surgical bypass has also been used for patients with malignant obstructions.